Michael Richman Archives · BioBuzz

Loading …

NextCure files for $92M IPO to advance Cancer Immunotherapy Pipeline

<img width="300" height="300" alt="" data-srcset="https://biobuzz.io/wp-content/uploads/2019/04/NextCure-logo-300x300.jpg 300w, https://biobuzz.io/wp-content/uploads/2019/04/NextCure-logo-100x100.jpg 100w, https://biobuzz.io/wp-content/uploads/2019/04/NextCure-logo-150x150.jpg 150w, https://biobuzz.io/wp-content/uploads/2019/04/NextCure-logo-75x75.jpg 75w" data-src="https://biobuzz.io/wp-content/uploads/2019/04/NextCure-logo-300x300.jpg" data-sizes="(max-width: 300px) 100vw, 300px" class="attachment-biobuzz-medium size-biobuzz-medium wp-post-image lazyload lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img width="300" height="300" src="https://biobuzz.io/wp-content/uploads/2019/04/NextCure-logo-300x300.jpg" class="attachment-biobuzz-medium size-biobuzz-medium wp-post-image lazyload" alt="" srcset="https://biobuzz.io/wp-content/uploads/2019/04/NextCure-logo-300x300.jpg 300w, https://biobuzz.io/wp-content/uploads/2019/04/NextCure-logo-100x100.jpg 100w, https://biobuzz.io/wp-content/uploads/2019/04/NextCure-logo-150x150.jpg 150w, https://biobuzz.io/wp-content/uploads/2019/04/NextCure-logo-75x75.jpg 75w" sizes="(max-width: 300px) 100vw, 300px" />

Published on : April 29, 2019April 30, 2019 Published by : Chris Frew

NextCure files for $92M IPO to advance Cancer Immunotherapy Pipeline April 29, 2019 NextCure, a clinical-stage biotech in Beltsville, MD developing cancer immunotherapies, announced the terms for its IPO that [….]